Evidence map›Paper›PMID 32245445›Full record

ArticleBMC public health2020

What are the drivers of recurrent cholera transmission in Nigeria? Evidence from a scoping review.

Kelly Osezele Elimian, Somto Mezue, Anwar Musah, Oyeronke Oyebanji, Ibrahima Soce Fall, Sebastian Yennan, Michel Yao, Patrick Okumu Abok, Nanpring Williams, Lynda Haj Omar and 8 more

Abstract readScoping Review
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Exploring the Impact of Traditional Practices onInternational journal of environmental research and public health · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Knowledge, Attitude, and Practice in a Sample of the Lebanese Population Regarding Cholera.International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kelly Osezele ElimianNigeria Centre for Disease Control, Abuja, Nigeria. kellyelimian@gmail.com.
Somto MezueUniversity of Benin, Benin, Nigeria.
Anwar MusahUniversity College London, London, UK.
Oyeronke OyebanjiNigeria Centre for Disease Control, Abuja, Nigeria.
Ibrahima Soce FallWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Sebastian YennanNigeria Centre for Disease Control, Abuja, Nigeria.
Michel YaoWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Patrick Okumu AbokWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Nanpring WilliamsNigeria Centre for Disease Control, Abuja, Nigeria.
Lynda Haj OmarWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Thieno BaldeWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Kobina AmpahWorld Health Organization, Abuja, Nigeria.
Ifeanyi OkudoWorld Health Organization, Abuja, Nigeria.
Luka IbrahimWorld Health Organization, Abuja, Nigeria.
Arisekola JinaduNigeria Centre for Disease Control, Abuja, Nigeria.
Wondimagegnehu AlemuWorld Health Organization, Abuja, Nigeria.
Clement PeterWorld Health Organization, Abuja, Nigeria.
Chikwe IhekweazuNigeria Centre for Disease Control, Abuja, Nigeria.

Funding

World Health Organization 001World Health Organization CONSULTANT - EMERGENCY CONTRACT NO: 202128944
6 · The paper itself

Abstract

backgroundThe 2018 cholera outbreak in Nigeria affected over half of the states in the country, and was characterised by high attack and case fatality rates. The country continues to record cholera cases and related deaths to date. However, there is a dearth of evidence on context-specific drivers and their operational mechanisms in mediating recurrent cholera transmission in Nigeria. This study therefore aimed to fill this important research gap, with a view to informing the design and implementation of appropriate preventive and control measures.

methodsFour bibliographic literature sources (CINAHL (Plus with full text), Web of Science, Google Scholar and PubMed), and one journal (African Journals Online) were searched to retrieve documents relating to cholera transmission in Nigeria. Titles and abstracts of the identified documents were screened according to a predefined study protocol. Data extraction and bibliometric analysis of all eligible documents were conducted, which was followed by thematic and systematic analyses.

resultsForty-five documents met the inclusion criteria and were included in the final analysis. The majority of the documents were peer-reviewed journal articles (89%) and conducted predominantly in the context of cholera epidemics (64%). The narrative analysis indicates that social, biological, environmental and climatic, health systems, and a combination of two or more factors appear to drive cholera transmission in Nigeria. Regarding operational dynamics, a substantial number of the identified drivers appear to be functionally interdependent of each other.

conclusionThe drivers of recurring cholera transmission in Nigeria are diverse but functionally interdependent; thus, underlining the importance of adopting a multi-sectoral approach for cholera prevention and control.

Indexed as

BibliometricsCholeraDisease OutbreaksDisease Transmission, InfectiousHumansNigeriaRecurrenceSystems AnalysisCholeraDriversMulti-sectoralScoping reviewTransmission

Identifiers

PMID32245445
PMCPMC7118857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.